Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study content or layout are evident.SummaryDifference0.0%

- Check17 days agoChange DetectedPublications section updated with a PubMed citation: Wang H, Yuan S, Wang H. Current Status of Research on Losartan in Tumour Therapy. J Cell Mol Med. 2026 Jan;30(1):e70985. Notes indicate the entry is automatically filled from PubMed and may not be about the study.SummaryDifference0.2%

- Check31 days agoChange DetectedAdded Location sections for Colorado, District of Columbia, Maryland, Massachusetts, New York, and Texas, and updated the page revision to v3.3.3; removed the previous location blocks (v3.3.2).SummaryDifference0.6%

- Check60 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2 with no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe government funding/status notice banner was removed from the page. The page now displays only the trial details and related information.SummaryDifference0.3%

- Check82 days agoChange DetectedNo additions or deletions were observed on the Study Details page; the content appears unchanged from the prior version.SummaryDifference0.4%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.